200 related articles for article (PubMed ID: 33419606)
1. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
[TBL] [Abstract][Full Text] [Related]
2. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
[TBL] [Abstract][Full Text] [Related]
3. SpaceOAR hydrogel spacer injection prior to stereotactic body radiation therapy for men with localized prostate cancer: A systematic review.
Payne HA; Pinkawa M; Peedell C; Bhattacharyya SK; Woodward E; Miller LE
Medicine (Baltimore); 2021 Dec; 100(49):e28111. PubMed ID: 34889268
[TBL] [Abstract][Full Text] [Related]
4. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Br J Radiol; 2021 Jan; 94(1117):20200848. PubMed ID: 33095659
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
6. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
[TBL] [Abstract][Full Text] [Related]
7. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
[TBL] [Abstract][Full Text] [Related]
8. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.
Wu SY; Boreta L; Wu A; Cheung JP; Cunha JAM; Shinohara K; Chang AJ
Brachytherapy; 2018; 17(2):259-264. PubMed ID: 29203149
[TBL] [Abstract][Full Text] [Related]
9. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
[TBL] [Abstract][Full Text] [Related]
10. Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer.
Zelefsky MJ; Pinitpatcharalert A; Kollmeier M; Goldman DA; McBride S; Gorovets D; Zhang Z; Varghese M; Happersett L; Tyagi N; Hunt M
Eur Urol Oncol; 2020 Dec; 3(6):748-755. PubMed ID: 31668713
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.
Yeh J; Lehrich B; Tran C; Mesa A; Baghdassarian R; Yoshida J; Torrey R; Gazzaniga M; Weinberg A; Chalfin S; Ravera J; Tokita K
Brachytherapy; 2016; 15(3):283-287. PubMed ID: 26853354
[TBL] [Abstract][Full Text] [Related]
12. Relationship between hydrogel spacer distribution and dosimetric parameters in linear-accelerator-based stereotactic body radiotherapy for prostate cancer.
Ohira S; Yamashita H; Minamitani M; Sawayanagi S; Ogita M; Imae T; Katano A; Nozawa Y; Ohta T; Nawa K; Nishio T; Koizumi M; Nakagawa K
J Appl Clin Med Phys; 2024 Jun; 25(6):e14294. PubMed ID: 38319652
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a rectal spacer with prostate SABR-first UK experience.
King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison.
Ogita M; Yamashita H; Nozawa Y; Ozaki S; Sawayanagi S; Ohta T; Nakagawa K
Radiat Oncol; 2021 Jun; 16(1):107. PubMed ID: 34118956
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
[TBL] [Abstract][Full Text] [Related]
16. Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapy.
Kobayashi H; Eriguchi T; Tanaka T; Ogata T; Ishida M; Nakajima Y; Kumabe A; Kosugi M
Int J Clin Oncol; 2021 Apr; 26(4):736-743. PubMed ID: 33415570
[TBL] [Abstract][Full Text] [Related]
17. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife.
Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y
J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658
[TBL] [Abstract][Full Text] [Related]
19. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
Dubouloz A; Rouzaud M; Tsvang L; Verbakel W; Björkqvist M; Linthout N; Lencart J; Pérez-Moreno JM; Ozen Z; Escude L; Zilli T; Miralbell R
Radiat Oncol; 2018 Jun; 13(1):114. PubMed ID: 29921291
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience.
Ozyigit G; Hurmuz P; Akinci D; Esen SCB; Yilmaz MT; Akdogan B; Akyol FH
Cancer Radiother; 2020 Dec; 24(8):805-811. PubMed ID: 32565071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
